Skip to main content
SpringerLink
Log in

Outcome of Operative Therapy of Hepatic Metastatic Stomach Carcinoma: A Retrospective Analysis

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

In general, hepatic metastasis from stomach carcinoma has an unfavorable prognosis. In addition, there are often further metastases in other organs, such as peritoneal carcinomatosis. The major aim of the present study was to investigate a potential curative surgical approach in these patients.

Material and methods

Thirty-one patients with hepatic metastases from stomach cancer were treated in the University Clinic Erlangen-Nürnberg. The data were collected retrospectively from 1972 to 1977 and prospectively since 1978 at the Erlangen Cancer Registry. The time frame of this retrospective analysis from patients who had surgical resection of hepatic metatases from gastric cancer was from 1972 to 2008. The median age of the patients was 65 years, and the ratio of men to women was 2:1.

Results

Atypical or anatomical resections of segments were possible in 21 cases. Larger operations, such as hemihepatectomy (right/left), were performed in 10 patients. The postoperative complication rate was 29%, and the hospital mortality was 6%. The five-year survival rate was 13%; R0 resection was achieved in 23 patients. We also found a significant difference in the 5-year survival rate between synchronous and metachronous metastases (0 vs. 29%; p < 0.001) and R0 resected patients (p = 0.002). Patients with solitary metastases had a significantly better median survival than patients with multiple metastases (21 vs. 4 months; p < 0.005.)

Conclusions

The overall survival in our study was 13%; therefore gastric cancer with liver metastases is not in every case a palliative situation. It seems that patients with liver metastases benefit from resection, especially if the metastases are metachronous (p < 0.001) and solitary, provided that a curative R0 resection has been achieved. An interdisciplinary approach with neoadjuvant chemotherapy appears useful. Additional controlled studies should be conducted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Al-Batran SE, Hartmann J, Probst S, Arbeitsgemeinschaft Internistische Onkologie et al (2008) Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. J Clin Oncol 26:1435–1442

    Article  PubMed  CAS  Google Scholar 

  2. Schmiegel W, Reinacher-Schick A, Arnold D et al (2008) Update S3-guideline “colorectal cancer” 2008. Z Gastroenterol 46:799–840 [in German]

    Article  PubMed  CAS  Google Scholar 

  3. Ojima H, Ootake S, Yokobori T et al (2007) Treatment of multiple liver metastasis from gastric carcinoma. World J Surg Oncol 5:70

    Article  PubMed  Google Scholar 

  4. Kutlu R, Sarac K, Yilmaz S et al (2005) Percutaneous right portal vein embolization with polyvinyl alcohol particles in gastric cancer metastasis: report of a case. Surg Today 35:765–769

    Article  PubMed  Google Scholar 

  5. Scheele J, Altendorf-Hofmann A, Grube T (2001) Resection of colorectal liver metastases: which prognostic factors should govern patient selection? Chirurg 72:547–560

    Article  PubMed  CAS  Google Scholar 

  6. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759–766

    Article  PubMed  Google Scholar 

  7. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15:938–946

    PubMed  CAS  Google Scholar 

  8. Goldsmith NA, Woodburne RT (1957) The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet 105:310–318

    PubMed  CAS  Google Scholar 

  9. Makino H, Kunisaki C, Izumisawa Y et al (2010) Indication for hepatic resection in the treatment of liver metastasis from gastric cancer. Anticancer Res 30:2367–2376

    PubMed  Google Scholar 

  10. Yedibela S, Göhl J, Graz V et al (2005) Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol 12:778–785

    Article  PubMed  Google Scholar 

  11. Laurent C, Rullier E, Feyler A et al (2001) Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 25:1532–1536. doi:10.1007/s00268-001-0164-7

    PubMed  CAS  Google Scholar 

  12. Lindell G, Ohlsson B, Saarella A et al (1998) Liver resection of noncolorectal secondaries. J Surg Oncol 69:66–70

    Article  PubMed  CAS  Google Scholar 

  13. Maksan SM, Lehnert T, Bastert G et al (2000) Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 26:209–212

    Article  PubMed  CAS  Google Scholar 

  14. Sakamoto Y, Ohyama S, Yamamoto J et al (2003) Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery 133:507–511

    Article  PubMed  Google Scholar 

  15. Van Ruth S, Mutsaerts E, Zoetmulder FAN et al (2001) Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol 27:662–667

    Article  PubMed  Google Scholar 

  16. Elias D, Cavalcanti de Albuqueque A, Eggenspieler P et al (1998) Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg 187:487–493

    Article  PubMed  CAS  Google Scholar 

  17. Harrison LE, Brennan MF, Newman E et al (1997) Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121:625–632

    Article  PubMed  CAS  Google Scholar 

  18. Okano K, Maeba T, Ishimura K et al (2002) Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 235:86–91

    Article  PubMed  Google Scholar 

  19. Ambiru S, Miyazaki M, Ito H et al (2001) Benefits and limits of hepatic resection for gastric metastases. Am J Surg 181:279–283

    Article  PubMed  CAS  Google Scholar 

  20. Hwang SE, Yang DH, Kim CY et al (2009) Prognostic factors for survival in patients with hepatic recurrence after curative resection of gastric cancer. World J Surg 33:1468–1472. doi:10.1007/s00268-009-0034-2

    Article  PubMed  Google Scholar 

  21. Adam R, Chiche L, Aloia T et al (2006) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244:524–535

    Article  PubMed  Google Scholar 

  22. Kakeji Y, Morita M, Maehara Y et al (2010) Strategies for treating liver metastasis from gastric cancer. Surg Today 40:287–294

    Article  PubMed  Google Scholar 

  23. Cheon SH, Rha SY, Jeung HC et al (2008) Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases. Ann Oncol 19:1146–1153

    Article  PubMed  CAS  Google Scholar 

  24. Tsujimoto H, Ichikura T, Ono S et al (2010) Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer. Hepatol Int 4:406–413

    Article  PubMed  Google Scholar 

  25. Tiberio GA, Coniglio A, Marchet A et al (2009) Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. Eur J Surg Oncol 35:486–491

    Article  PubMed  CAS  Google Scholar 

  26. Chau I, Norman A, Cunningham D et al (2004) Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer—pooled analysis from three multicenter, randomized, controlled trials using individual patient data. J Clin Oncol 22:2395–2403

    Article  PubMed  Google Scholar 

  27. Zacherl J, Zacherl M, Scheuba C et al (2002) Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 6:682–689

    Article  PubMed  Google Scholar 

  28. Choi SB, Song J, Kang CM et al (2010) Surgical outcome of metachronous hepatic metastases secondary to gastric cancer. Hepatogastroenterology 57:29–34

    PubMed  Google Scholar 

  29. Van Cutsem E, Moiseyenko VM, Tjulandin S et al (2006) V325 Study Group Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. J Clin Oncol 24:4991–4997

    Article  PubMed  Google Scholar 

  30. Nishiyama M, Wada S (2009) Docetaxel: its role in current and future treatments for advanced gastric Cancer. Gastric Cancer 12:132–141

    Article  PubMed  CAS  Google Scholar 

  31. Al-Batran SE, Hartmann JT, Hofheinz R et al (2008) Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie. Ann Oncol 19:1882–1887

    Article  PubMed  Google Scholar 

  32. Vecchione L, Orditura M, Ciardiello F et al (2009) Novel investigational drugs for gastric cancer. Expert Opin Investig Drugs 18:945–955

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Erlangen/Nürnberg, Erlangen, Germany

    Claus W. Schildberg, R. Croner, S. Merkel, V. Schellerer, V. Müller, S. Yedibela, W. Hohenberger, G. Peros & A. Perrakis

  2. Department of Surgery, Cancer Registry, University of Erlangen/Nürnberg, Erlangen, Germany

    S. Merkel

Authors
  1. Claus W. Schildberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Croner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Merkel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. V. Schellerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Yedibela
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Hohenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Peros
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Perrakis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus W. Schildberg.

Additional information

C. W. Schildberg and R. Croner equally contributed to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schildberg, C.W., Croner, R., Merkel, S. et al. Outcome of Operative Therapy of Hepatic Metastatic Stomach Carcinoma: A Retrospective Analysis. World J Surg 36, 872–878 (2012). https://doi.org/10.1007/s00268-012-1492-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-012-1492-5

Keywords

Search

Navigation